A detailed history of Geode Capital Management, LLC transactions in Volitionrx LTD stock. As of the latest transaction made, Geode Capital Management, LLC holds 634,548 shares of VNRX stock, worth $380,728. This represents 0.0% of its overall portfolio holdings.

Number of Shares
634,548
Previous 617,366 2.78%
Holding current value
$380,728
Previous $469,000 17.48%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$0.59 - $0.91 $10,137 - $15,635
17,182 Added 2.78%
634,548 $387,000
Q1 2024

May 13, 2024

BUY
$0.72 - $1.19 $43,166 - $71,344
59,953 Added 10.76%
617,366 $469,000
Q4 2023

Feb 13, 2024

BUY
$0.55 - $0.88 $10,434 - $16,695
18,972 Added 3.52%
557,413 $401,000
Q3 2023

Nov 13, 2023

BUY
$0.69 - $1.53 $50,526 - $112,037
73,227 Added 15.74%
538,441 $371,000
Q2 2023

Aug 11, 2023

BUY
$1.39 - $2.02 $239,758 - $348,425
172,488 Added 58.92%
465,214 $646,000
Q4 2022

Feb 13, 2023

BUY
$1.39 - $2.6 $6,074 - $11,362
4,370 Added 1.52%
292,726 $711,000
Q2 2022

Aug 12, 2022

BUY
$1.96 - $3.05 $10,891 - $16,948
5,557 Added 1.96%
288,356 $591,000
Q1 2022

May 13, 2022

BUY
$2.41 - $3.24 $32,081 - $43,130
13,312 Added 4.94%
282,799 $851,000
Q4 2021

Feb 11, 2022

SELL
$3.02 - $4.13 $4,025 - $5,505
-1,333 Reduced 0.49%
269,487 $846,000
Q3 2021

Nov 12, 2021

BUY
$2.98 - $3.48 $25,979 - $30,338
8,718 Added 3.33%
270,820 $839,000
Q2 2021

Aug 13, 2021

SELL
$3.01 - $3.78 $697,398 - $875,803
-231,694 Reduced 46.92%
262,102 $862,000
Q1 2021

May 12, 2021

BUY
$3.33 - $6.5 $295,813 - $577,414
88,833 Added 21.94%
493,796 $1.87 Million
Q4 2020

Feb 12, 2021

BUY
$2.88 - $4.33 $144,023 - $216,534
50,008 Added 14.09%
404,963 $1.58 Million
Q3 2020

Nov 13, 2020

BUY
$2.94 - $4.05 $5,706 - $7,861
1,941 Added 0.55%
354,955 $1.14 Million
Q2 2020

Aug 13, 2020

BUY
$2.89 - $4.32 $428,243 - $640,141
148,181 Added 72.34%
353,014 $1.37 Million
Q4 2019

Feb 13, 2020

SELL
$4.28 - $5.95 $53,208 - $73,970
-12,432 Reduced 5.72%
204,833 $970,000
Q3 2019

Nov 12, 2019

BUY
$2.97 - $6.42 $267,163 - $577,504
89,954 Added 70.66%
217,265 $1.22 Million
Q2 2019

Aug 14, 2019

BUY
$2.93 - $3.6 $77,413 - $95,115
26,421 Added 26.19%
127,311 $399,000
Q2 2017

Aug 14, 2017

BUY
N/A
100,890
100,890 $357,000

Others Institutions Holding VNRX

About VOLITIONRX LTD


  • Ticker VNRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 57,297,000
  • Market Cap $34.4M
  • Description
  • VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...
More about VNRX
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.